Sequoia Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Sequoia Financial Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.35M	Sell	162,082 -978	-0.6%	-$13.2K	0.01%	571
2026 Q1	$2.26M	Buy	163,060 +23,553	+17%	+$328K	0.01%	563
2025 Q4	$1.96M	Buy	139,507 +14,452	+12%	+$203K	0.01%	578
2025 Q3	$1.75M	Sell	125,055 -10,495	-8%	-$151K	0.01%	576
2025 Q2	$2.04M	Buy	135,550 +61,964	+84%	+$885K	0.01%	466
2025 Q1	$971K	Sell	73,586 -9,643	-12%	-$133K	0.01%	622
2024 Q4	$1.31M	Buy	83,229 +5,014	+6%	+$75.3K	0.01%	503
2024 Q3	$1.24M	Buy	78,215 +180	+0.2%	+$2.9K	0.01%	479
2024 Q2	$1.19M	Buy	78,035 +5,405	+7%	+$77.5K	0.01%	444
2024 Q1	$1.07M	Buy	72,630 +1,160	+2%	+$16.9K	0.01%	457
2023 Q4	$995K	Buy	71,470 +2,505	+4%	+$33.5K	0.01%	527
2023 Q3	$922K	Buy	68,965 +755	+1%	+$10.2K	0.02%	361
2023 Q2	$861K	Buy	68,210 +10,625	+18%	+$124K	0.01%	377
2023 Q1	$656K	Sell	57,585 -70	-0.1%	-$756	0.01%	400
2022 Q4	$597K	Buy	57,655 +31,270	+119%	+$337K	0.01%	389
2022 Q3	$276K	Sell	26,385 -6,805	-21%	-$72.5K	0.01%	405
2022 Q2	$368K	Buy	+33,190	New	+$361K	0.01%	392

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sequoia Financial Advisors's RDY Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 0.6% in Q2 2026, selling an estimated $13.2K and leaving 162,082 shares worth $2.35M. The position accounts for 0.01% of the portfolio, ranked #571.

Sequoia Financial Advisors first reported a position in RDY in Q2 2022 and has held it in 17 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Sequoia Financial Advisors held 162,082 shares of Dr. Reddy's Laboratories worth $2.35M as of Q2 2026.
Sequoia Financial Advisors sold 978 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $13.2K.
Dr. Reddy's Laboratories made up 0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #571 holding.
Sequoia Financial Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2022 and has held it in 17 quarters since.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.